Transcriptomic Analysis of Equine Chorioallantois Reveals Immune Networks and Molecular Mechanisms Involved in Nocardioform Placentitis by El-Sheikh Ali, Hossam et al.
University of Kentucky 
UKnowledge 
Maxwell H. Gluck Equine Research Center 
Faculty Publications Maxwell H. Gluck Equine Research Center 
7-8-2021 
Transcriptomic Analysis of Equine Chorioallantois Reveals 
Immune Networks and Molecular Mechanisms Involved in 
Nocardioform Placentitis 
Hossam El-Sheikh Ali 
University of Kentucky 
Shavahn C. Loux 
University of Kentucky, shavahn.loux@uky.edu 
Laura Kennedy 
University of Kentucky, drlaurakennedy@uky.edu 
Kirsten E. Scoggin 
University of Kentucky, kirsten.scoggin@uky.edu 
Pouya Dini 
University of Kentucky, pouya.dini@uky.edu 
See next page for additional authors 
Follow this and additional works at: https://uknowledge.uky.edu/gerc_facpub 
 Part of the Large or Food Animal and Equine Medicine Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
El-Sheikh Ali, Hossam; Loux, Shavahn C.; Kennedy, Laura; Scoggin, Kirsten E.; Dini, Pouya; Fedorka, 
Carleigh E.; Kalbfleisch, Ted S.; Esteller-Vico, Alejandro; Horohov, David W.; Erol, Erdal; Carter, Craig N.; 
Smith, Jackie L.; and Ball, Barry A., "Transcriptomic Analysis of Equine Chorioallantois Reveals Immune 
Networks and Molecular Mechanisms Involved in Nocardioform Placentitis" (2021). Maxwell H. Gluck 
Equine Research Center Faculty Publications. 59. 
https://uknowledge.uky.edu/gerc_facpub/59 
This Article is brought to you for free and open access by the Maxwell H. Gluck Equine Research Center at 
UKnowledge. It has been accepted for inclusion in Maxwell H. Gluck Equine Research Center Faculty Publications 
by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Transcriptomic Analysis of Equine Chorioallantois Reveals Immune Networks 
and Molecular Mechanisms Involved in Nocardioform Placentitis 
Digital Object Identifier (DOI) 
https://doi.org/10.1186/s13567-021-00972-4 
Notes/Citation Information 
Published in Veterinary Research, v. 52, issue 1, article no. 103. 
© The Author(s) 2021 
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits 
use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give 
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, 
and indicate if changes were made. The images or other third party material in this article are included in 
the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If 
material is not included in the article's Creative Commons licence and your intended use is not permitted 
by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The 
Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/
1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. 
Authors 
Hossam El-Sheikh Ali, Shavahn C. Loux, Laura Kennedy, Kirsten E. Scoggin, Pouya Dini, Carleigh E. 
Fedorka, Ted S. Kalbfleisch, Alejandro Esteller-Vico, David W. Horohov, Erdal Erol, Craig N. Carter, Jackie L. 
Smith, and Barry A. Ball 
This article is available at UKnowledge: https://uknowledge.uky.edu/gerc_facpub/59 
El‑Sheikh Ali et al. Vet Res          (2021) 52:103  
https://doi.org/10.1186/s13567‑021‑00972‑4
RESEARCH ARTICLE
Transcriptomic analysis of equine 
chorioallantois reveals immune networks 
and molecular mechanisms involved 
in nocardioform placentitis
Hossam El‑Sheikh Ali1,2, Shavahn C. Loux1, Laura Kennedy3, Kirsten E. Scoggin1, Pouya Dini1, 
Carleigh E. Fedorka1, Theodore S. Kalbfleisch1, Alejandro Esteller‑Vico4, David W. Horohov1, Erdal Erol3, 
Craig N. Carter3, Jackie L. Smith3 and Barry A. Ball1*  
Abstract 
Nocardioform placentitis (NP) continues to result in episodic outbreaks of abortion and preterm birth in mares and 
remains a poorly understood disease. The objective of this study was to characterize the transcriptome of the cho‑
rioallantois (CA) of mares with NP. The CA were collected from mares with confirmed NP based upon histopathology, 
microbiological culture and PCR for Amycolatopsis spp. Samples were collected from the margin of the NP lesion 
(NPL, n = 4) and grossly normal region (NPN, n = 4). Additionally, CA samples were collected from normal postpartum 
mares (Control; CRL, n = 4). Transcriptome analysis identified 2892 differentially expressed genes (DEGs) in NPL vs. CRL 
and 2450 DEGs in NPL vs. NPN. Functional genomics analysis elucidated that inflammatory signaling, toll‑like receptor 
signaling, inflammasome activation, chemotaxis, and apoptosis pathways are involved in NP. The increased leukocytic 
infiltration in NPL was associated with the upregulation of matrix metalloproteinase (MMP1, MMP3, and MMP8) and 
apoptosis‑related genes, such as caspases (CASP3 and CASP7), which could explain placental separation associated 
with NP. Also, NP was associated with downregulation of several placenta‑regulatory genes (ABCG2, GCM1, EPAS1, and 
NR3C1), angiogenesis‑related genes (VEGFA, FLT1, KDR, and ANGPT2), and glucose transporter coding genes (GLUT1, 
GLUT10, and GLUT12), as well as upregulation of hypoxia‑related genes (HIF1A and EGLN3), which could elucidate 
placental insufficiency accompanying NP. In conclusion, our findings revealed for the first time, the key regulators 
and mechanisms underlying placental inflammation, separation, and insufficiency during NP, which might lead to the 
development of efficacious therapies or diagnostic aids by targeting the key molecular pathways.
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Introduction
Nocardioform placentitis (NP) is defined as a focal 
mucoid placental inflammation in which the bacterial 
infection is limited to the chorionic surface of the ventral 
placenta without infection of the fetus [1, 2]. NP was 
first diagnosed in central Kentucky (KY) in 1986 [3] with 
subsequent epizootics occurring there in 1998, 1999, 
2011, 2017, and 2020 [1, 4]. Cases of NP have also been 
reported sporadically in Florida [5], South Africa [6], Italy 
[7] and most recently in New Zealand [8]. NP is charac-
terized by late-term abortions, premature foals, neonatal 
deaths, and weak foals at term associated with an appar-
ent fetal growth retardation due to placental separation 
Open Access
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and insufficiency with large areas of the chorion that may 
be involved with the lesion [1]. NP lesions may also be 
seen in the CA in mares with normal neonates. The dis-
tribution of the placental lesion in NP is distinct from 
those of ascending bacterial placentitis with lesions of 
NP mainly distributed in the cranial-ventral portion of 
the placenta near the junction of the uterine horns and 
body [1]. The lesion is often sharply demarcated from the 
surrounding normal placenta, and the affected placenta 
is covered with a thick, tan mucoid material [1, 2]. His-
tologically, the chorioallantois may demonstrate infiltra-
tion of neutrophils, lymphocytes, and macrophages with 
hyperplasia of the chorionic epithelium [1]. The surface 
exudate contains sloughed epithelial cells, leukocytes and 
an eosinophilic, amorphous material. Centrally, the cho-
rionic villi are blunted and atrophied with lymphocytic 
infiltrates [1].
Nocardioform placentitis is associated with gram-pos-
itive, branching actinomycetes including Amycolatopsis 
spp., and Crossiella equi along with more recently char-
acterized isolates of Streptomyces atriruber and Strep-
tomyces silaceus, among others [9]. Characterization of 
actinomycetes associated with abortions during the 2011 
outbreak of NP in central Kentucky revealed that Amyco-
latopsis spp. (49% of cases) was the most common, with 
Crossiella equi (29% of cases) as the next most frequent 
isolate [10].
To date, the pathogenesis of the disease remains poorly 
understood. Attempts to induce the infection in mares by 
intrauterine inoculation of Crossiella equi at the time of 
breeding or in pregnant mares via oral, intravenous, and 
intranasal routes with Crossiella equi were unsuccessful 
[11]. Like pathogenesis, the ecology and biology of the 
causative organisms, Crossiella equi and Amycolatop-
sis spp. remain unknown, as these organisms have only 
been isolated from affected placentae in mares. Addition-
ally, the pathophysiology of the NP and the key regulators 
underlying placental inflammation, separation and insuf-
ficiency during NP remains unclear. These gaps in our 
knowledge about the disease are limiting the advance-
ment toward efficient diagnostic, prevention and treat-
ment protocols for NP.
The application of high-dimensional biology, such as 
RNA-sequencing could aid in revealing the NP tran-
scriptomic signature, identifying the immune networks 
and pathways involved in NP with consequent elucida-
tion of the pathophysiology of the disease. The better 
understanding of these key regulators and mechanisms 
holds potential for the development of new diagnostic 
tools and therapies to forestall NP-induced preterm 
labor. Therefore, the current study aimed to compare 
the transcriptomic changes in the CA of mares with 
NP with tissues collected from unaffected regions of 




During the 2017 foaling season, thoroughbred mares in 
central KY with suspected nocardioform placentitis had 
placental tissues collected at the time of foaling or abor-
tion for subsequent histopathologic evaluation as well as 
RNA isolation. Within three hours of foaling/abortion, 
two samples were taken from the CA at the margin of the 
NP lesion (NPL, Figure 1A) using an 8-mm biopsy punch. 
One sample was fixed in 10% formalin, and one sample 
was preserved in RN = Alater® (#AM7021; Invitrogen). 
In addition, two samples were also taken from a normal-
appearing region of the CA (NP normal; NPN, Figure 1A) 
over the uterine body and preserved as mentioned above. 
Tissues were handled carefully to avoid contamination 
with soil, manure, bedding or other foreign material. The 
remaining CA was submitted to the University of Ken-
tucky Veterinary Diagnostic Laboratory for complete 
gross and histopathologic evaluation, as well as microbi-
ology and PCR for Amycolatopsis spp. and Crossiella equi 
[10]. Among the collected cases, four cases (NPL = 4 and 
NPN = 4) were confirmed as Nocardioform placentitis 
(Amycolatopsis spp.) based upon microscopic examina-
tion of the placenta (presence of gram-positive branch-
ing bacilli) and confirmation by PCR [10]. Additionally, 
normal postpartum placenta (Control; CRL, n = 4) were 
collected from four normal foaling mares, and these pla-
centae were also examined at the UKVDL to confirm 
normal placenta based upon pathological and microbio-
logical examination.
Total RNA extraction
Total RNA was isolated from all CA samples using the 
RNeasy Mini Kit (#74,104; Qiagen), and DNA digestion 
was performed on-column using RNase-free DNase I 
(#79,254: Qiagen), followed by cleanup procedures. All 
procedures were performed according to the manufac-
turer’s instructions. After extraction, RNA concentration 
and quality were analyzed using a Nanodrop 2000 spec-
trophotometer (#ND-2000; Thermo Fisher Scientific) 
and the Bioanalyzer® (Agilent, Santa Clara, CA, USA). 
All samples had a 260/280 ratio > 2.0 and RNA integrity 
number (RIN) > 9.0.
Next‑generation RNA sequencing (RNA‑seq)
Next-generation RNA-seq was performed at the Uni-
versity of Louisville Center for Genetics and Molecu-
lar Medicine as described elsewhere [12]. In brief, the 
mRNA libraries were prepared from total RNA using 
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Figure 1 Sampling sites from the nocardioform placentitis group and the histopathological evaluation of inflammation score. A In 
the nocardioform placentitis group we collected chorioallantois samples from two sites. The fist sampling site (NPL) was at the margin of the 
nocardioform placentitis lesion. The second sampling site (NPN) was chosen where the chorionic surface is red and velvet in appearance with no 
gross evidence of pathology. B, C The inflammation score in the different sets (CRL, NPN, and NPL) and reprehensive H&E images of the different 
inflammation scores. The inflammation was graded as score zero (no inflammation; no inflammatory cells), score 1 (mild inflammation; few 
leukocyte infiltration), score 2 (moderate inflammation; moderate leukocyte infiltration), and score 3 (marked inflammation; large numbers of 
inflammatory cells).
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TruSeq® Stranded mRNA Library Prep (#20,020,594; 
Illumina). Libraries were diluted to 10  nM, pooled, fur-
ther diluted and denatured to single strand and run on 
a NextSeq 500 v2 (Illumina, San Diego, CA, USA) 300 
cycle, High Output kit in a 2 × 150 bp PE read.
Bioinformatics pipeline
Reads were trimmed for quality and adapters with Trim-
Galore 0.4.3, then mapped to EquCab3.0 using STAR 
2.5.3a [13]. Expression values (Fragments Per Kilobase 
of transcript per Million fragments mapped; FPKM) of 
mapped reads were quantified using Cufflinks 2.2.1 [14] 
with the ENSEMBL annotation (ENSEMBL v.88). Dif-
ferentially expressed genes (DEGs) were evaluated using 
Cuffdiff 2.2.1 based upon a false discovery rate (FDR) 
adjusted p-value < 0.05 after Benjamini–Hochberg cor-
rection for multiple-testing [14]. The DEGs were repre-
sented as heatmaps using the R-package “gplots” [15]. 
The overlap between DEGs in the NPL vs. CRL, NPL vs. 
NPN and NPN vs. CRL was illustrated with Venn dia-
grams using BioVenn and UpSet. The current RNA-seq 
data was deposited in the Gene Expression Omnibus 
(GEO; GSE154637) repository. The bioinformatics and 
functional genomics pipeline is summarized and illus-
trated in Additional file 1.
Functional genomics
To investigate the biological functions of DEGs, DAVID 
Bioinformatics Resources version 6.8 along with the 
PANTHER pathways version 13.0 were used to function-
ally annotate genes based on gene ontology (biological 
process and pathways).
To predict upstream regulators relevant for each set of 
DEGs, upstream regulator analysis was carried out using 
Ingenuity pathway analysis (IPA, 2018) as described 
elsewhere [12]. To investigate the interaction and rela-
tionships between the potential upstream regulators, all 
known protein–protein interactions were referenced and 
matched using String version 10.5. The resultant interac-
tion networks were visualized using Cytoscape version 
2.8.3.
Weighted gene co-expression network analysis was car-
ried out using WGCNA version 1.66 package in R [16] to 
construct gene co-expression networks as described else-
where [17]. Gene co-expression clusters were generated 
from the all DEGs in NPL as described elsewhere [12]. In 
brief, following the construction of a matrix of pairwise 
correlations between all pairs of genes across the samples 
(n = 12), a weighted adjacency matrix was generated by 
raising co-expression similarity to a power β = 9 as deter-
mined for these sample sets. Then, a topological overlap 
matrix (TOM) was assembled and used as input for hier-
archical clustering analysis. Then, a dynamic tree-cutting 
algorithm was used to identify gene modules or clusters 
(i.e., genes with high topological overlap). Gene clusters 
were visualized by the heatmap plot (TOM plot) of the 
gene network topological overlap. Module relationships 
were summarized by a hierarchical clustering dendro-
gram and TOM plot of module eigengenes (MEs). The 
associations between the gene clusters and the score of 
the trait of interest (i.e., inflammation score for each sam-
ple) were tested by correlating MEs to trait score. GO 
analysis (biological process) was performed on gene lists 
derived from module of interest. Module memberships 
(MM, i.e., the correlation between each gene’s expression 
profile with the ME of a given module as an indicator 
of the intramodular connectivity) and gene significance 
(GS, i.e., the correlation between the gene expression 
profile (FPKM) and the trait score (inflammation score) 
as a measure of biological relevance) were calculated 
[18]. The genes (network nodes) having MM ≥ 0.90, 
p-value < 0.05 and GS ≥ 0.6 were identified as intramodu-
lar hub genes [19].
To further investigate the cross-talk between DEGs 
in NP, we matched our DEGs with the available ligand–
receptor pairs in the FANTOM5 database for pro-
tein-coding genes [20]. This dataset includes 2557 
ligand-receptor interactions.
Validation of RNA‑seq using quantitative RT‑PCR
For gene expression analysis, total RNA was reverse 
transcribed using TaqMan™ Reverse Transcription Rea-
gents (#4,368,814; Invitrogen™). RT-qPCR was per-
formed using PowerUp™ SYBR™ Green Master Mix 
(#A25741; Applied Biosystems™) along with specific 
primers designed for a subset of six selected targets 
using Primer-BLAST (NCBI) as described in Table  1, 
with actin beta (ACTB) and glucuronidase beta (GUSB) 
as reference genes based on Normfinder software (ver-
sion 0.953) as described elsewhere [21]. PCR efficiency 
was evaluated using LinRegPCR (version 11.0) to ensure 
that all evaluated transcripts resulted in a PCR efficiency 
between 1.8 and 2.2 [22]. Delta CT (ΔCT) values calcu-
lated where ΔCT = (CT values of mRNA of interest—CT 
value of the reference genes). Results are presented as 
-ΔCT. One-way ANOVA was used to evaluate the sig-
nificance of any changes in mRNA expression of tested 
targets between CRL, NPN and NPL groups, followed by 
a pairwise comparison of means using unpaired T-test. 
Differences of P < 0.05 were considered as statistically 
significant and any difference of 0.1 > P ≥ 0.05 was consid-
ered a trend. Pearson’s correlation was used to examine 
the correlation between mRNA expression results from 
RT-qPCR (−ΔCT) and the RNA-sequencing (normalized 
FPKM:  Log2[FPKM + 1]) for each transcript. Descriptive 
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statistics are expressed below as the mean ± standard 
error of the mean (SEM).
Tissue preparation for histopathological examination 
and immunohistochemical staining
The fixed full-thickness CA samples were dehydrated, 
embedded in paraffin using routine methods, and sec-
tioned at 5  μM. For histopathological examination, 
sections were stained with hematoxylin and eosin. 
The inflammation score was determined based on the 
amount of inflammation in the placenta and was graded 
as zero (no inflammation; no inflammatory cells), 1 
(mild inflammation; few leukocyte infiltration), 2 (mod-
erate inflammation; moderate leukocyte infiltration) 
and 3 (severe inflammation; large numbers of inflam-
matory cells). Average scores for placenta were calcu-
lated for each sample based on random evaluation of 
three different high-power fields. The inflammation 
score and representative H&E images of the different 
scores are shown in Figures 1B and C.
For IHC, immunostaining of sectioned tissues was 
conducted using mouse anti-human calgranulin B 
(S100A9 1:1000, #MA1-81381 ThermoFisher Scien-
tific), mouse anti-human caspase 7 (CASP7 1:200, #SC-
28295, Santa Cruz Biotechnology), mouse anti-human 
hypoxia inducible Factor 1 subunit alpha (HIF1A 
1:200,#MA1-16504, ThermoFisher Scientific), mouse 
anti-human vascular endothelial growth factor (VEGF 
1:50, # MA5-13182, ThermoFisher Scientific), rabbit 
anti human T-Box Transcription Factor 21 (TBX21 
1:400, #PA5-28881, ThermoFisher Scientific), and rab-
bit anti-human cytochrome P450 family 11 subfamily 
A member 1 (CYP11A1 1:1000, # NBP1-85368, Novus 
Biologicals). Paraffin sections were processed with 
the Leica BOND-MAX system (Leica Microsystems, 
Buffalo Grove, IL, USA) as described elsewhere [23]. 
Slides were evaluated at 100 and 200× magnification.
Statistical analysis
An unpaired T-test was used to evaluate the signifi-
cance of any changes in gestational age and foal birth-
weight between control and NP groups. One-way 
analysis of variance (one-way ANOVA) was used to 
evaluate the significance of any changes in inflamma-
tion score between CRL, NPN, and NPL, followed by 
a pairwise comparison of means using Tukey’s honestly 
significant difference (HSD) post hoc test. Differences 
of P < 0.05 were considered as statistically significant 
and any difference of 0.1 > P ≥ 0.05 was considered 
a trend. Descriptive statistics are expressed as the 
mean ± standard error of the mean (SEM).
Results
Clinical and technical data
The four confirmed nocardioform placentitis (Amyco-
latopsis spp.) cases and four control mares delivered live 
foals at term (Table  2). The birthweights of foals born 
to mares with NP were lower (P = 0.025). Gestational 
lengths did not show significant difference (P = 0.14) 
between mares with NP and controls (Table  2). Further 
details about mares clinical and histopathological find-
ings are presented in Additional file  2. The integrity of 
RNA recovered from both NP and control tissues was 
very high (RIN > 9; Table 3).
Transcriptomic profiling and coverage
In total, 94.44 million reads were generated from all 
cDNA libraries, with an average of 7.87 million reads 
per sample. An average of 86.9% (range 85.7–88.2%) 
Table 1 Forward and reverse primer sequences used for RT‑qPCR analysis 
Primers were generated using Primer‑BLAST (NCBI).
Key: RT‑qPCR, Real time quantitative polymerase chain reaction; NCBI, National Center for Biotechnology Information; IL1β, Interleukin 1β; IL1RN, Interleukin 1 
Receptor Antagonist; IL6, Interleukin 6; PLAC8, Placenta‑specific 8; SAA1, Serum Amyloid A1; INHBA, Inhibin Subunit Beta A; ACTB, actin beta; GUSB, Glucuronidase 
Beta.
Gene Forward Reverse Accession Amplicon 
size (bp)
IL1β CAG TCT TCA GTG CTC AGG TTT CTG CAT TGC CGC TGC AGT AAG T XM_001495926.4 84
IL1RN GCC TGT GTC AAG TCT GGT GA ACT CTT TGG GCT TGT TGG TG XM_005599766.3 217
IL6 GGA TGC TTC CAA TCT GGG TTC AAT TCC GAA AGA CCA GTG ATG ATTTT NM_001082496.2 65
PLAC8 GTT TCA TGT GCC TTG CGT TGT ATA TCG GGT CCG GTA GAG GG XM_003364673.4 98
SAA1 CCT GGG CTG CTA AAG TCA TC AGG CCA TGA GGT CTG AAG TG XM_023646155.1 169
INHBA CCT CCT CTT CCT TCT TCT TCT TCT T GCA AGA GCT CCC TGG ATA TT XM_023638729.1 99
GUSB GGG ATT CGC ACT GTG GCT GTCA CCA GTC AAA GCC CTT CCC TCGGA XM_001493514 117
ACTB CGA CAT CCG TAA GGA CCT GT CAG GGC TGT GAT CTC CTT CT NM_001081838 100
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of reads was mapped to the equine reference genome 
(EquCab3.0). FPKM distribution and principal compo-
nent analysis (PCA) of the equine CA transcriptome 
from mares in CRL, NPN, and NPL is depicted in Fig-
ures  2A  and B. Further details about individual sample 
read count, and mapping quality are presented in Addi-
tional file 3.
Differential gene expression
The differentially expressed genes (DEGs) in NPL vs. 
CRL, NPN vs. CRL and NPL vs. NPN and the overlap 
between these DEGs are represented in Figures  2C–F 
and Additional file  4. CA from NPL exhibited differen-
tial expression (FDR < 0.05) of 2892 genes (1898 upregu-
lated and 994 downregulated) relative to CRL. Moreover, 
CA from NPL exhibited differential expression of 2450 
genes (1580 upregulated and 870 downregulated) relative 
to NPN. A total of 2189 DEGs were shared in common 
between NPL vs. CRL and NPL vs. NPN (Figure  2D). 
Gene expression of the CA from CRL and NPN clustered 
together suggesting relatively fewer differences in gene 
expression (i.e., 89 DEGs) between the two sample sets. 
This might suggest that NP have a lesser impact on the 
chorioallantois beyond the lesion zone.
Gene ontology (GO) enrichment and pathway analysis
Functional annotation of DEGs in NPL demonstrated 
that these genes were mainly involved in biological pro-
cesses associated with inflammatory response, immune 
response, immunoglobulin mediated immune response, 
cellular response to lipopolysaccharide, toll-like recep-
tor signaling pathway, B cell receptor signaling pathway, 
defense response to virus, angiogenesis, and chemot-
axis, among others (Figures 3A and B). Moreover, path-
way analysis of DEGs in NPL revealed that these genes 
are involved in relevant pathways such as inflammatory 
signaling (interleukin signaling, inflammation mediated 
by chemokine and cytokine signaling pathway, toll-like 
receptor signaling, B cell activation, and T cell activa-
tion), angiogenesis-related pathways (VEGF signaling, 
angiogenesis, endothelin signaling pathway and PDGF 
signaling pathway), cytostructural integrity (integrin 
signaling pathway), and apoptosis signaling pathway, 
among others (Figures 4A and B). 
Upstream regulators and their targets
The upstream regulator analysis identified 73 activated 
upstream regulators (P-value of overlap is < 0.05 and 
Table 2 Summary of mare data for tissue collections from nocardioform placentitis and control mares 
Different superscripts (a and b) indicate significant difference within the same column.




Foal outcome Foal birthweight
(pounds)
Interval from foaling 




4 11.3 ± 2.4 337 ± 9.3 4 live foals 114 ± 12.3a 106 ± 48
Control 4 9.3 ± 0.8 348 ± 6.6 4 live foals 138.8 ± 11.4b 38 ± 13
Table 3 RNA integrity of chorioallantois collected from NP 
and control mares 
Category RNA integrity 
number (RIN)
Nocardioform lesion 9.5 ± 0.3
Nocardioform normal 9.7 ± 0.3
Control 9.75 ± 0.26
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Figure 2 Transcriptomic Analysis of the Chorioallantois (CA) from Mares with Nocardioform Placentitis. A Violin plot showing transcripts’ 
FPKM distribution in CA in control (CRL), nocardioform placentitis lesion (NPL), and nocardioform placentitis normal region (NPN) sets. The plots 
display the distribution of the data using kernel density plots (outer shapes). The inner horizontal lines show the interquartile range (the two 
outer thin lines), the median (the central thick line). B Principal component analysis (PCA) of the equine CA transcriptome from mares in CRL, NPN, 
and NPL sets. C Heat map of differentially expressed genes (DEGs; FDR < 0.05) in NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. The heat map 
was created using the normalized FPKMs of the DEGs (log10 [FPKM of the DEG + 1]). Normalized expression values are indicated on a color scale 
with red indicating high expression (positive z‑score) and green indicating low expression (negative z‑score). The circles at the bottom indicate 
the sample group (green = CRL, yellow = NPN, and red = NPL). The heat map was generated using the R package “heatmap.2”. D Venn diagram 
representing DEGs in common between NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. E UpSet diagram illustrating the intersection between 
DEGs (upregulated and downregulated) in NPL vs. CRL, NPL vs. NPN, and NPN vs. CRL sets. The nature of each intersection is indicated by the dots 
below the vertical bar plot. The vertical bars show the number of DEGs in each intersection, while the horizontal bars show the number of DEGs in 
each comparison. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 3 Overrepresented biological process in equine chorioallantois (CA) in NPL vs. CRL and NPL vs. NPN sets. Gene ontology (GO) 
enrichment analysis was used to identify the overrepresented biological process from the DEGs in NPL vs. CRL set (A) and NPL vs. NPN set (B). 
The biological processes are visualized by GOplot package in R “GOCircle “. The inner circle is a bar chart where the height of the bar denotes the 
significance of the GO term (− log10 adjusted P‑value), and color links to the z‑score. The outer circle displays dot plots of the logFC for the genes in 
each term. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 4 Overrepresented PANTHER pathways in equine chorioallantois (CA) in NPL vs. CRL and NPL vs. NPN sets. PANTHER pathway 
analysis was used to identify the overrepresented pathways from the DEGs in in NPL vs. CRL set (A) and NPL vs. NPN set (B). The bars represent the 
number of genes in each overrepresented pathway, and the dotted line represents –Log10 (Adj P‑value). Key; CRL; normal postpartum (control), 
NPL; nocardioform placentitis lesion, NPN; nocardioform placentitis normal region, PANTHER; Protein ANalysis THrough Evolutionary Relationships.
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Figure 5 Potential upstream regulators in equine chorioallantois (CA) during nocardioform placentitis (NP) as identified by upstream 
regulator analysis performed on Ingenuity Pathway Analysis (IPA). A Venn diagram representing potential upstream regulators in common 
between NPL vs. CRL and NPL vs. NPN sets. B Protein–protein interactions network between upstream regulators identified NPL vs. CRL and NPL 
vs. NPN sets. Protein–protein interactions network was generated by STRING version 10.3. and visualized with Cytoscape 2.8.6. Red circles indicate 
activated upstream regulator, while green circle indicate inhibited upstream regulator. Key; CRL; normal postpartum (control), NPL; nocardioform 
placentitis lesion, and NPN; nocardioform placentitis normal region.
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Figure 6 Weighted gene expression co‑expression network analysis (WGCNA) of DEGs in equine chorioallantois (CA) during 
nocardioform placentitis dataset. A Gene module (clusters) identification as determined by WGCNA. B Matrix with the module‑trait relationships 
and corresponding p‑values of the modules on the y‑axis and selected traits related with treatment on the x‑axis. The y‑axis is colored according 
to the correlation, with red representing a strong positive correlation and green representing a strong negative correlation. C Number of genes 
per module. D, E Module‑trait correlation heatmap based on correlation analysis of module eigengenes (MEs) and inflammation score in placenta 
(n = 12). The turquoise, yellow, and brown modules presented a significant positive correlation with inflammation score (p‑values < 0.05). F 
Over‑represented biological process in the turquoise module. G A scatter plot of GS for inflammation score versus the MM in the turquoise module.
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Z-score ≥ 2) among the DEGs in both NPL vs. CRL and 
NPL vs. NPN (Figure 5A). Those activated upstream regu-
lators included 55 regulators in common between both sets. 
Those 55 regulators include genes coding for transcription 
factors (ETS1, IRF1, IRF7, MYBL2, NFAT5, NFKB2, PML, 
REL, RELB, SPL1, STAT1, STAT2 and STAT4), transmem-
brane receptors (CD2, CD40, ICAM1, SELP, TLR2, TLR3, 
TLR5, and TLR7), and cytokines (CCL5, CD40LG, FLT3LG, 
IL1A, IL1B, IL7, IL18, TNFSF10, TNFSF13B), among oth-
ers. Also, this analysis identified nine inhibited upstream 
regulators (P-value of overlap is < 0.05 and Z-score ≤ -2) 
among the DEGs in both NPL vs. CRL and NPL vs. NPN. 
Those inhibited upstream regulators included seven regu-
lators (A2M, AGA , B4GALNT1, CBX7, CREM, DAG1, 
and NR3C1) in common between both sets. The identified 
upstream regulators and their target molecules in NPL vs. 
CRL and NPL vs. NPN are represented in Additional files 
5A and B, respectively. The overlap between identified 
potential upstream regulators in NPL vs. CRL and NPL vs. 
NPN is depicted in Figure  5A. Moreover, the interaction 
between identified potential upstream regulators is illus-
trated in Figure 5B.
Weighted co‑expression network analysis (WGCNA)
WGCNA was carried out to gain further insights on the 
DEGs co-expression patterns and to identify the genes 
with the highest interaction or connectivity (hub genes) 
among those DEGs in NPL vs. CRL and NPL vs. NPN. 
Co-expression analysis of the DEGs in NPL identified 
five gene modules (clusters) as presented in Figure 6 and 
Additional file  6. Among these modules, turquoise, yel-
low and brown modules were positively associated with 
inflammation score. But the blue module was negatively 
correlated to this trait. It is worth noting that, the tur-
quoise module showed the highest adjacency to inflam-
mation score trait as presented in Figure 6E.
Ligand‑receptor interaction analysis
To gain further insights on the interaction between DEGs, 
ligand-receptor interaction analysis identified 1038 possible 
interactions in NP. These interactions elucidate the impact 
of NP on placental autocrine and paracrine signaling in 
comparison to normal parturition. A representative set of 
Ligand-receptor interactions is presented in Figure 7 and the 
complete list of interactions is provided in Additional file 7.
RT‑qPCR validation
RT-qPCR confirmed the differential expression of six 
genes in NPL in comparison to CRL and/or NPN group 
as illustrated in Figure  8. Analysis of the correlation 
between gene expression results from RT-qPCR (−ΔCT) 
and the RNA-sequencing (normalized FPKM) showed 



































































































































Figure 7 Ligand‑receptors interaction analysis of DEGs during nocardioform placentitis. Genes shown in red are significantly upregulated 
in the chorioallantois (CA) from the nocardioform placentitis lesion (NPL) in comparison to normal postpartum (CRL). Genes shown in green are 
significantly downregulated in NPL in comparison to CRL. Genes shown in black are those that did not show any significant change in NPL in 
comparison to CRL.
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Immunohistochemistry
The protein localization and staining intensity for CASP7, 
TBX21, VEGF, S100A9, CYP11A1, HIF1A, and SAA1 
in equine CA retrieved from CRL, NPN, and NPL sets 
are shown in Figure 9. Based upon immunolocalization, 
CASP7 was predominantly expressed in the nucleus and 
cytoplasm of chorionic epithelium in NPL compared 
to CRL and NPN. S100A9 and TBX21 appeared to be 
mainly expressed in immune cells in CA retrieved from 
CRL, NPN, and NPL with a higher number of S100A9 
Figure 8 RT‑qPCR validation of six selected differentially expressed genes from RNA‑sequencing results. Expression of each mRNA was 
determined by qRT‑PCR, normalized to ACTB and GUSB, expressed as −∆CT. Data are presented as a dot plot, and the middle horizontal line 
represents the mean while error bars represent the standard error of the mean (SEM). Asterisks indicate the presence of a significant difference 
between groups (*P < 0.05; **P < 0.01, *** P < 0.001). Dagger (†) indicates the presence of a trend (0.1 > P ≥ 0.05). Pearson’s correlation coefficient (r) 
between mRNA expression results from RT‑qPCR (−ΔCT) and the RNA‑sequencing (FPKM) is represented for each transcript. Key; IL1β, Interleukin 
1β; IL1RN, Interleukin 1 Receptor Antagonist; IL6, Interleukin 6; PLAC8, Placenta‑specific 8; SAA1, Serum Amyloid A1; INHBA, Inhibin Subunit Beta A; 
ACTB, actin beta; GUSB, Glucuronidase Beta.
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Figure 9 Representative photomicrographs of the equine placenta retrieved from CRL, NPN, NPL, and immunostained for S100A9, 
CASP7, HIF1A, VEGF, TBX21, and CYP11A1. Bar = 100 µm. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis lesion, and NPN; 
nocardioform placentitis normal region, CASP7; caspase 7, HIF1A; hypoxia inducible Factor 1 subunit alpha, VEGF; vascular endothelial growth factor, 
CYP11A1; cytochrome P450 family 11 subfamily A member 1.
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and TBX21 positive cells in NPL. The expression of both 
VEGF and CYP11A1 was predominant in the cytoplasm 
of the chorionic epithelium. VEGF showed a higher 
immunolabeling intensity in CA retrieved from CRL and 
NPN compared to NPL. In contrast, CYP11A1 showed 
a higher immunolabeling intensity in CA retrieved 
from NPL compared to CRL and NPN. HIF1A was 
mainly expressed in the nucleus of chorionic epithelium, 
endothelial cells and vascular smooth muscle cells in 
blood vessels as well as scattered stromal cells within the 
CA with a higher number of HIF1A positive cells in NPL 
set. It is worth noting that inflammatory cells did not dis-
play any positive immunolabeling for HIF1A. Overall, the 
immunostaining intensity for all evaluated targets was 
consistent with the transcript expression in the current 
RNA-Seq dataset.
Discussion
To the authors’ knowledge, this is the first study to assess 
transcriptomic changes in the CA of mares with sponta-
neous NP (Amycolatopsis spp.). The current study pre-
sents a distinct transcriptome signature of equine NP 
(Amycolatopsis spp.) and adds to the understanding of 
the key regulators and molecular mechanisms involved in 
the disease. Overall, a large number of genes were differ-
entially expressed between NP-lesion and control mares, 
which is similar to studies on equine ascending placen-
titis [24–26] and human intra-amniotic infections [27]. 
Our results revealed that NP is dominated by Toll-like 
receptor signaling, inflammasome activation, inflamma-
tory signaling and apoptosis. Although, the current study 
focused on the characterization of NP transcriptome 
associated with Amycolatopsis spp, which is the most 
common bacteria associated with this disease, further 
studies are still warranted to assess the transcriptome of 
NP associated with other bacteria (e.g., Crossiella equi, 
Streptomyces atriruber and Streptomyces silaceus).
Although, the NPN samples didn’t show significant 
difference in macroscopic and microscopic appearance 
(i.e., inflammation score) compared to CRL samples, we 
identified 89 DEGs in NPN vs. CRL set. This transcrip-
tomic difference could be attributed to exocrine mol-
ecules released from the lesion (NPL) and consequently 
affect the transcriptome of unaffected tissue (NPN). This 
notion is supported by two recent retrospective studies 
which have described the serum profile of mares with 
focal mucoid placentitis (n = 6; two placentas were PCR 
positive for the Amycolatopsis ssp, while the other four 
had no bacteria detected) and found alterations in endo-
crine, cytokine, and feto-secretory markers in the weekly 
assessed samples [28, 29]. In brief, these showed an 
increase in IL-2, IL-5, IL-6, IL-10 and TNF in the mater-
nal serum. Interestingly, the present study revealed that 
IL-6 is a potential upstream regulator for the DEGs iden-
tified in NPL vs. NPN dataset, which again supports our 
notion. Additionally, the relatively small number of DEGs 
in the NPN vs. CRL set was reflected in the close cluster-
ing of NPN and CRL samples (low inflammation score) 
far from NPL samples (high inflammation score) in the 
PCA and the heatmap. Noteworthy, the present study 
identified 2189 DEGs (represent 69.5% of DEGs) in com-
mon between NPL vs. CRL and NPL vs. NPN sets. These 
DEGs are the main focus of this discussion section unless 
otherwise stated.
The central role of inflammatory mediators during pla-
cental infections is well established in women, mice and 
mares [12, 30–32]. Likewise, the current study demon-
strated that equine NP is principally dominated by inflam-
matory and immune responses, as revealed by functional 
genomics analysis of DEGs. In brief, the NP transcrip-
tome revealed the upregulation of a set of genes encod-
ing the key regulators of the inflammatory cascade. These 
include pattern recognition receptors (PRRs) such as 
Toll-like receptors (TLRs) and Nod-like receptors (NLRs). 
Of note TLRs  are the primary and earliest recognition 
mechanism for pathogen associated molecular patterns 
(PAMPs) unique to the microorganisms with subsequent 
activation of the inflammatory cascade [33, 34]. In the 
present study, several TLRs (TLR1,  TLR2,  TLR3,  TLR5, 
TLR7 and TLR8) were significantly upregulated in NP. It 
is noteworthy that TLR1/TLR2 heterodimers are respon-
sible for recognition of gram-positive bacteria, consistent 
with the Amycolatopsis spp. infection. Meanwhile, TLR5 
is responsible for recognition of bacterial flagellin [33]. 
On the other hand, TLR3, TLR7 and TLR8 are respon-
sible for recognition of viruses [33]. The upregulation of 
the later TLRs might suggest presence of a viral compo-
nent accompanying NP and/or indicate the upregula-
tion of ligands that could activate these receptors [33]. 
This notion was somewhat supported by the overex-
pression of viral-related pathways (defense response to 
virus and negative regulation of viral genome replica-
tion) in NPL as indicated by gene ontology analysis. 
Upstream regulator analysis revealed the central role of 
TLRs (2, 3, 5, 7, and 8) in NP. Furthermore, TLR2, TLR7, 
and TLR8 showed up as hub genes in the turquoise mod-
ule in the WGCNA database. Taking all together, these 
findings address the principal role of TLRs as key regula-
tors triggering the inflammatory cascade associated with 
NP. Strategies to block TLRs hold potential for therapies 
to block the inflammatory cascade and to forestall NP. 
This notion is supported by studies showing that TLR 
antagonists (TLRAs) were highly effective in prevent-
ing preterm birth induced by lipopolysaccharides (LPS), 
heat-killed E.  coli or platelet activating factor (PAF) in 
primates and mice [35, 36].
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NLR signaling is a critical component in inflammasome 
activation [37]. Inflammasomes are cytosolic multi-pro-
tein complexes that orchestrate the inflammatory cascade 
[38]. Recently, we have elucidated that inflammasome 
activation is implicated in equine ascending placentitis 
[24]. Similarly, several inflammasome-related transcripts 
(NLRC4, NLRC5, CASP1, IL1B, IL18, and GSDMD) were 
significantly upregulated during NP in the current study. 
Moreover, NLRC4, NLRC5, IL1B, IL18, and GSDMD 
showed up as hub genes in the turquoise module in the 
WGCNA database. Furthermore, IL1B and IL18 showed 
up as upstream regulators in the present study. Taken all 
together, these findings address the crucial role of NLRs 
in triggering the inflammatory response associated with 
NP. Therefore, targeting NLRs along with TLRs dur-
ing NP might be promising for blocking the inflamma-
tory cascade and to forestall placentitis-induced preterm 
birth. This notion is supported by recent studies show-
ing that the treatment of intra-amniotic infection using 
NLR inflammasome inhibitors [39] resulted in inhibition 
of prostaglandin synthesis with subsequent prevention of 
infection-associated preterm birth in mice.
Among the mediators of inflammatory pathways, 
chemokines are crucial for the activation and recruitment 
of immune cells to the infection site [34, 40–43]. The 
infiltrating immune cells are implicated in local inflam-
mation, partly by releasing cytokine and matrix metallo-
proteinases (MMPs). These molecular events have been 
reported in human chorioamnionitis and equine ascend-
ing placentitis [24, 34, 40–43]. Similarly, in the present 
study, members of these gene groups of chemokines (e.g., 
CCL2, CCL8, CCL5, CXCL6, and S100A9), cytokines 
(e.g., IL1α, IL1β, IL6, IL7, IL15 and IL18), and MMPs 
(e.g., MMP1, MMP3, MMP8, and MMP12) were upregu-
lated during NP. The upregulation of MMPs is implicated 
in extracellular matrix (ECM) degradation and apoptosis 
[24, 44–48]. Likewise, the apoptosis signaling pathway 
and several apoptosis-related genes (CASP3,  CASP4, 
CASP7, CASP8, and CASP10) were overexpressed during 
NP. The implication of MMPs and apoptosis in placental 
separation have been described during term and pre-
term labor in women, mares and ruminants [24, 44–48]. 
Among the previously discussed molecules, IL1α, IL1β, 
IL6, IL7, IL18, CCL5, S100A9, and CASP3 showed up as 
upstream regulators for NP. Moreover, CCL (2, 3, 7, and 
8), CXCL (6, 8, and 10), IL (1α, 1β, 6, 7, 18), CASP (3, 4, 7, 
8, and 10), S100A9 and MMP8 showed up as hub genes in 
NP as elucidated by WGCNA. Additionally, our results 
revealed that the infiltrating immune cells significantly 
affected the transcriptomic signature of nocardioform 
placentitis. For instance, the inflammation score trait (i.e., 
degree of immune cell infiltration) showed the highest 
adjacency to the turquoise module, which is the largest 
module (includes 54.71% of DEGs) in WGCNA dataset. 
Therefore, the DEGs in this module might be triggered by 
the infiltration of the placenta by immune cells. In sup-
port, pathway analysis of these DEGs revealed that they 
are involved in pathways related to inflammatory cascade 
and immune response. Taken together, these findings 
highlight the central role of immune cells in orchestrat-
ing the localized placental inflammation and consequent 
placental separation during NP.
Although the recruitment of immune cells to the infec-
tion site is a principal element of the innate immune 
response against the invading pathogenic microorgan-
ism, host defense peptides (HDPs), also known as anti-
microbial peptides (AMPs), represent another vital 
element in this immune response [49–51]. HDPs repre-
sent potent and broad-spectrum antimicrobial proper-
ties. The expression of genes coding for HDPs is induced 
by transcription factors due to the activation of  TLRs 
[49–51]. We recently reported that equine ascend-
ing placentitis is associated with upregulation of sev-
eral genes coding for HDPs [24]. In agreement, NP was 
associated with upregulation of several HDPs such as 
lysozyme (LYZ), peptidase inhibitor 3 (PI3), secretory 
phospholipase A2  (sPLA2; PLA2G2A), myeloid catheli-
cidin 3 (ECATH3), granulysin (GNLY),  secretory leu-
kocyte peptidase inhibitor (SLPI), acid phosphatase 5, 
tartrate resistant (ACP5), and psoriasis (S100A7). In line 
with our findings, the upregulation of several HDPs has 
been reported in women with intra-amniotic infection 
[52, 53] and mares with ascending placentitis [24]. Addi-
tionally, several reports have described the impressive 
in vivo activities of HDPs [54, 55]. As a result, there has 
been growing interest in HDPs as new treatment strate-
gies for bacterial infections [54, 55]. So far, the efficacy 
of HDPs as a potential treatment for equine NP has not 
been tested.
In addition to the activation of the innate immune 
response, NP also appears to lead to an upregulation of 
the adaptive immune system, including T cell lympho-
cyte development and proliferation. T cell lymphocytes 
are believed to be crucial for pregnancy maintenance 
and proper embryo development, in addition to antigen-
specific defense against pathogen [56, 57]. While Th1 and 
Th2 cell types are essential for defense against intracellu-
lar and extracellular pathogens respectively, it is the bal-
ance between Th17 and Treg response which allows the 
body to carry the pregnancy to term [24]. A disruption 
of this balance has been indicated in various pregnancy-
related complications, including amniotic and placental 
infection [58–60] and recurrent unexplained abortion 
[61–64]. In the present study, NP was associated with an 
increase in factors relating to the Th1 response (STAT1, 
STAT4, TBX21, IL15, IL18). An upregulation of various 
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Th17-related transcripts was associated with NP (BATF, 
IL17RC, IL21R, S100A9), but this was alongside a simi-
lar increase in Treg-related transcripts (CXCR4, SELL, 
IL2RA, IL10RA). An increasing Th17 response along with 
a dysregulated Treg response has been noted in various 
types of pregnancy-related complications [57, 59, 63, 65, 
66], and yet both apparently increased in NP. This dual 
increase may explain the response to the pathogen and 
the chronic nature of this disease, as all affected fetuses 
resulted in live birth. The expression pattern of T-cells 
related transcripts in NPL vs. CRL is summarized in 
Figure 10.
In the current study, placental inflammation 
was associated with aberrant expression of several 
placenta-regulatory genes. For example, placenta-specific 
8 (PLAC8), and galectin 1 (LGALS1) were significantly 
upregulated during NP, while placenta-specific ATP-
Binding Cassette Transporter (ABCG2), chorion-specific 
transcription factor GCMa (GCM1), endothelial PAS 
domain protein 1 (EPAS1), and nuclear receptor sub-
family 3 group C member 1 (NR3C1) were significantly 
downregulated during the disease. Similarly, we recently 
reported that equine ascending placentitis is accom-
panied by abnormal expression of PLAC8, LGALS1, 
ABCG2, GCM1, and NR3C1 [24, 67]. It is likely that the 
altered expression of these placenta-regulatory genes will 
adversely affect the placental functions during placentitis.
Figure 10 Schematic illustration elucidating the expression pattern of T. cells related transcripts during NPL in comparison to CRL. The 
FPKM of the selected genes were extracted from the transcriptome dataset and analyzed using student T‑test. The arrow directions indicate if the 
transcript is upregulated or downregulated in NPL in comparison to CRL. Key; CRL; normal postpartum (control), NPL; nocardioform placentitis 
lesion, TBX21; T‑Box Transcription Factor 21, IL; Interleukin, STAT; signal transducer and activator of transcription.
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Within the NP transcriptome signature, we identified 
aberrant expression of genes in insulin-like growth fac-
tor (IGF) signaling: IGFBP2, IGFBP6, IGFR1, and IGFR2. 
The upregulation of the IGFBP2 and IGFBP6 could have 
multiple paracrine and autocrine consequences through-
out the context of NP. Secreted IGFBP2 and IGFBP6 
have a high affinity for IGF1 and IGF2, respectively, 
reducing their bioavailability to activate IGF signaling 
[68]. Similarly, we have recently reported that equine 
ascending placentitis is associated with upregulation of 
IGFBP2, IGFBP4, and IGFBP7, and downregulation of 
IGFR1 [24]. It is noteworthy that placental IGF signal-
ing is implicated in fetal growth [69, 70]. Therefore, the 
upregulation of IGFBP2 and IGFBP6 and downregu-
lation of IGFR1 and IGFR2 during NP may suggest a 
reduction in IGF signaling, consistent with the lower 
birthweight we reported in the current study. Addition-
ally, the present study revealed altered expression of sev-
eral solute carrier (SLCs) genes. Of note, SLC is a family 
of membrane-bound proteins (more than 300 proteins) 
that facilitate the transport of a wide range of substrates 
across biological membranes, including the placenta [71]. 
Our results revealed downregulation of approximately 31 
SLCs, including glucose transporters (SLC2A1, SLC2A10, 
and SLC2A12), amino acids transporters (SLC7A1, and 
SLC38A4), fatty acids transporters (FABP1, FABP3, 
VLDLR SLC25A17, SLC27A1 and SLC25A17), vitamin 
transporters (SLC19A3), and adenosine triphosphate 
(ATP) transporter (SLC25A17), among others. The down-
regulation of the above-mentioned SLCs could result in 
a decline in transportation of maternal nutrients to the 
growing fetus. Again, these findings are consistent with 
lower birthweight of foals in the current study. Moreover, 
our results showed that NP was associated with dysregu-
lation of angiogenesis, as reflected by the downregula-
tion of angiogenesis-related genes (e.g.,  VEGFA,  KDR, 
ANGPT2 and FLT1). Angiogenesis dysregulation could 
result in a decline in placental blood perfusion (ischemia) 
and, consequently, hypoxia in placental tissues [72]. This 
notion is supported by the upregulation of hypoxia-
related genes (HIF1A and EGLN3) in NPL. Therefore, the 
use of medicaments that improve placental angiogenesis 
and/or blood flow might be beneficial for NP treatment. 
Overall, the previously discussed molecular mechanisms 
underlying dysregulation of placental angiogenesis and 
nutrient transportation, as well as placental hypoxia, 
could explain placental insufficiency during NP.
Identifying the gene expression signature that is intrin-
sic for equine NP is potential for future in  vitro and/or 
in  vivo studies. Additionally, if the proteins coded by 
these genes are released from the placentitis lesion into 
the maternal circulation and can be measured, these pro-
teins might serve as reliable and sensitive biomarkers 
for equine NP. The current study revealed that 105 
genes were exclusively expressed in NPL in comparison 
to control (i.e., zero FPKM in CRL set). Some of these 
transcripts encode proteins that have been proposed 
as potential biomarkers for intra-amniotic infection or 
inflammation in women with preterm labor [73, 74], 
such as ENSECAG00000008686 (psoriasis; S100A7) and 
ENSECAG00000010615 (calgranulin B; S100A9). On 
the other hand, the top ten exclusively expressed genes 
(based on abundance in NPL) were novel genes. Gene 
homology analysis of these ten genes revealed that six 
of them are homologous to human and mouse immuno-
globulin kappa constant (IGKCs; ENSECAG00000001923 
and ENSECAG00000001923), immunoglobulin 
lambda constant (IGLCs; ENSECAG00000015109, 
ENSECAG00000031522, and ENSECAG00000039599), 
and immunoglobulin heavy variable (IGHVs; 
ENSECAG00000028730), while the remaining four genes 
did not show any homology to human and mouse genes. 
Further studies are required to assess the utility of the 
immunoglobulins as potential biomarkers for equine 
NP. Overall, these NP exclusively expressed transcripts 
represent an intrinsic signature for equine NP, and fur-
ther studies are required to elucidate their role in the NP 
pathway. Further studies to assess their associate proteins 
as potential biomarkers for equine NP are warranted.
In the present study, the RNA integrity of RNA iso-
lated from CA collected within three hours after foaling 
was consistently high (RIN > 9) which suggests that this 
sampling strategy of collecting CA on farm and preser-
vation in RNAlater® could be effective for further stud-
ies on term equine placenta. This observation is similar 
to studies of human term placenta where preservation of 
decidua in RNA later yielded high RNA integrity [75].
There are some potential limitations to our study. These 
limitations relate to obtaining samples at the beginning 
of the disease because nocardioform placentitis is always 
diagnosed in the disease’s late stages, and it is difficult to 
obtain prepartum samples from clinical cases. Moreover, 
there is no valid experimental model for the disease that 
would us to collect samples at the early stages of the dis-
ease. Similar to these limitations, human studies that are 
concerned with clinical chorioamnionitis or spontane-
ous preterm birth use a similar sampling time point (i.e., 
no samples are obtained at the beginning of the disease), 
and results from these studies are still acknowledged in 
human reproductive science [34, 40]. Furthermore, it is 
believed that the bacterial infection during NP starts at 
the center of the lesion and then progresses/expands out-
ward. Therefore, we believe that the current sampling site 
(i.e., the margin of the lesion [NPL]) would reflect many 
of the molecular mechanisms associated with the early 
interaction between the bacteria and the chorioallantois. 
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In conclusion, on-farm collection of the CA from mares 
within three hours after foaling yielded RNA suit-
able for analysis by high-throughput sequencing. This 
is the first study to describe the equine CA transcrip-
tome during NP. Our results revealed the central role 
of TLRs and NLRs in triggering the inflammatory sign-
aling and inflammasome activation, respectively, dur-
ing NP, and this resulted in placental inflammation and 
immune cell chemotaxis. The increased leukocytic infil-
tration was associated with the upregulation of MMPs 
and apoptosis-related genes, believed to be implicated in 
placental separation during NP. NP was associated with 
aberrant expression of several placenta-regulatory genes 
and dysregulation of placental angiogenesis, and nutri-
ent transportation, as well as placental hypoxia, which 
could explain placental insufficiency during NP. The sig-
nificant findings of the current dataset are summarized 
in Figure 11. Beyond the NP-associated events described 
in the current study, this study provides a comprehen-
sive database of the key upstream regulators, TFs, hub 
genes, receptor-ligand interactions, gene co-expression 
networks associated with equine nocardioform placenti-
tis. Strategies to block the key upstream regulators (e.g., 
TLRs and NLRs) and associated pathways hold potential 
Figure 11 Schematic illustration explaining the possible mechanisms associated with equine nocardioform placentitis in light of the 
current study. The arrow directions indicate if the gene is upregulated or downregulated in the current study.
Page 20 of 22El‑Sheikh Ali et al. Vet Res          (2021) 52:103 
for therapies to overcome NP. Together, the currently 
revealed placentitis transcriptome signature improves 
our understanding of the disease. Also, it provides an all-
essential basis for the construction of new hypotheses to 
be tested in the future. Finally, much more valuable infor-
mation remains to be mined from the current transcrip-
tome dataset.
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